BUSINESS
Johnson & Johnson
BUSINESS
J&J begins crucial battle over US$10bil baby powder settlement
BUSINESS
J&J tops quarterly profit estimates on cancer drug sales
BUSINESS
J&J lifts profit and sales forecasts, beats Wall Street expectations
BUSINESS
Cancer victims lose bid to block proposed J&J talc bankruptcy
BUSINESS
Johnson & Johnson reaches US$700mil talc case settlement
BUSINESS
J&J must pay US$260mil in latest talc trial, says Oregon jury
BUSINESS
Cancer victims sue Johnson & Johnson over ‘fraudulent’ bankruptcies
BUSINESS
J&J wins trial over Florida woman who claimed talc caused cancer
BUSINESS
J&J can contest evidence linking its talc to cancer, US judge rules
BUSINESS
J&J settles first talc cases
BUSINESS
J&J’s dengue pill shows promise in first human challenge trial
BUSINESS
Court tosses US$223.8mil verdict against J&J in talc cancer case
BUSINESS
J&J unveils new logo after 135 years
BUSINESS
Doctor asks court to toss J&J lawsuit against her
BUSINESS
J&J talc cancer plaintiffs want 6-month ban on bankruptcy filings
BUSINESS
J&J faces new trial over talc cancer claims
BUSINESS
J&J’s consumer unit named in talcum powder cancer claims
WORLD
Judge urged to dismiss J&J talc unit second bankruptcy
BUSINESS
J&J talc unit again seeks to halt 38,000 cancer lawsuits
BUSINESS
J&J proposes US$8.9bil settlement of talc cancer claims
WORLD
J&J loses challenge to US$302 mil judgment over pelvic mesh marketing
BUSINESS
J&J to pay US$40.5mil in New Hampshire opioid case
BUSINESS